Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05650541 · ClinicalTrials.gov registry record · NA
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
A NA study of Heart Failure, sponsored by Analog Device.
- Recruiting
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
- 7
- Study locations
NCT05650541 is a NA study of Heart Failure that is actively recruiting participants, run by Analog Device. The registered enrollment target is 1,200 participants, below the 2,046-participant average among 397 other Heart Failure trials with a reported enrollment target (41% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT05650541, a NA study of Heart Failure, is actively recruiting participants, sponsored by Analog Device.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
- 7
- Study locations
Study Summary
The primary purpose for this study is to support the hypothesis (pilot data) that the use of the Sensinel CPM system reduces the rate of HF-related events and the related healthcare cost. The study will also measure the impact on quality of care and patient satisfaction. In order to support the primary objective, the study will compare the outcomes and costs for patients using the Sensinel CPM system against those who are not. This can either be done using institutions' averages, if available, or through a control group.
Conditions Studied
Interventions
- DEVICE CardioPumlonary Management System
Study Locations (7)
Florida
- Baptist Health South Florida - Miami
- Orlando Health - Orlando
California
- Desert Oasis Healthcare - Palm Springs
Massachusetts
- Baystate Medical Center - Springfield
Nebraska
- University of Nebraska Medical Center - Omaha
North Carolina
- Cone Health - Greensboro
South Carolina
- Prisma Health - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2023-09-22 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05650541
The ClinicalTrials.gov registry entry for NCT05650541 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,046-participant average among 397 other Heart Failure trials with a reported enrollment target (41% lower). The listed sponsor is Analog Device, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CardioPumlonary Management System is the first listed.
NCT05650541 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Florida, California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05650541 about?
NCT05650541 is a clinical study titled "Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure". The primary purpose for this study is to support the hypothesis (pilot data) that the use of the Sensinel CPM system reduces the rate of HF-related events and the related healthcare cost. The study will also measure the impact on quality of care and patient satisfaction. In order to support the prim...
What is the current status of trial NCT05650541?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2023-09-22. Estimated completion is 2026-06-01.
What conditions does trial NCT05650541 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT05650541?
The interventions under investigation include: CardioPumlonary Management System (DEVICE).
Who is sponsoring clinical trial NCT05650541?
This trial is sponsored by Analog Device, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05650541 being conducted?
This trial has 7 study locations across California, Florida, Massachusetts, Nebraska, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.